Pieris
AcquiredPieris is headquartered in Hallbergmoos, Germany and lists 51–200 employees.
- Headquarters
- Hallbergmoos
- Employees
- 51–200
- Business Model
- B2B
- Website
- pieris.com
- Acquisition Date
- Dec 2024
Indexed holds 2 investors for this company. The full record is or through the API.
About
Pieris Pharmaceuticals is a clinical-stage biopharmaceutical company pioneering Anticalin proteins - a novel class of therapeutic biologics derived from human lipocalins. The company focuses on bispecific fusion proteins targeting oncology and respiratory diseases.
Summary
Pieris is a Biotech company based in Hallbergmoos, Germany. It lists 51–200 employees. Investors include Bayern Kapital and Forbion Capital Partners.
Exit History
Dec 2024
Sign up to see all 2 events
Funding, valuations, and company events, with amounts and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/pieris"><img src="https://indexed.vc/api/badge/company/pieris" alt="Pieris on Indexed.vc" width="260" height="76" /></a>